Attend live and virtual events that provide a platform for education and collaborative discussion about the management of kidney disease and strategies to improve kidney health.
Any NephU member can request a presentation for their region or organization at no charge.
This presentation will examine the clinical overlap between CKD and major depressive disorder (MDD) in symptomatology, behavioral and biological mechanisms, the impact of co-morbid depression on CKD outcomes, and strategies for effective management of depression in CKD.
Patient empowerment is an important concept in the care of patients with chronic kidney disease. Join us for an informational webinar, where Dr. Saundra Jain and Dr. Rima Kang discuss motivational interviewing techniques and the role of communication in patient empowerment.
Many Black people in the U.S. are born into a life of trauma, and this trauma is born from a history of repression, violence, injustice, and inhumanity. This trauma is not something any of us who have not been Black in America can ever fully understand; it is a very personal, lived experience. The goal […]
Many Black people in the U.S. are born into a life of trauma, and this trauma is born from a history of repression, violence, injustice, and inhumanity. This trauma is not something any of us who have not been Black in America can ever fully understand; it is a very personal, lived experience. The goal […]
COVID-19 can have significant impact on the kidneys and on patients with kidney disease. In this event, Dr. Green, Dr. Maringer, and Dr. Lockwood will discuss the currently known pathophysiology of COVID-19 and important considerations in the care of patients with kidney disease. *Speakers are employees or paid consultants of Otsuka Pharmaceutical Development & Commercialization, […]
There is a high prevalence of depression among patients with chronic kidney disease (CKD). This presentation will examine the clinical overlap between CKD and major depressive disorder (MDD) in symptomatology, behavioral and biological mechanisms, the impact of comorbid depression on CKD outcomes, and strategies for effective management of depression in CKD. *Speakers are employees or […]
There is a high prevalence of depression among patients with chronic kidney disease (CKD). This presentation will examine the clinical overlap between CKD and major depressive disorder (MDD) in symptomatology, behavioral and biological mechanisms, the impact of comorbid depression on CKD outcomes, and strategies for effective management of depression in CKD. *Speakers are employees or […]
Most improvements in healthcare outcomes are attributed to clinical, operational, or financial process changes. However, patients can also play a considerable role in improving their care. Listen in as we explore patient empowerment and shared decision-making concepts, specific to patients suffering from kidney disease. By recognizing the potential benefit of empowered patients, it shifts the […]
Leaders in nephrology will discuss healthcare challenges amidst COVID-19, telemedicine, and the future of nephrology.
Leaders in nephrology will discuss healthcare challenges amidst COVID-19, telemedicine, and the future of nephrology. *Speakers are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc (OPDC). Tazin Aijaz, PharmD, BCPS is an employee of OPDC. Featured Speakers Location Online via NephU.org
There is a high prevalence of depression among patients with chronic kidney disease (CKD). This presentation will examine the clinical overlap between CKD and major depressive disorder (MDD) in symptomatology, behavioral and biological mechanisms, the impact of comorbid depression on CKD outcomes, and strategies for effective management of depression in CKD. Objectives Discuss the high […]
A Virtual Live Event for PsychU & NephU members in the New York state region. There is a high prevalence of depression among patients with chronic kidney disease (CKD). This presentation will examine the clinical overlap between CKD and major depressive disorder (MDD) in symptomatology, behavioral and biological mechanisms, the impact of comorbid depression on […]
